1. D.P. Byar, C. Blackard, and VACURG, Comparison of Placebo, Pyridoxine & Topical Thiotepa in Preventing Recurrence of Stage I Bladder Cancer, Urology 10: 556 (1977).
2. R.J. Cross, R.W. Glashan, C.S. Humphrey, H.R.G. Robinson, P.H. Smith, and R.E. Williams, Treatment of Advanced Bladder Cancer with Adriamycin and 5 Fluorouracil, Brit. J. Urol. 48: 609 (1976).
3. F. Edsmyr, T. Berlin, J. Boman, P.L. Esposti, H. Gustafson, H. Wikström, M. Duchek, and S. Eksborg, Intravesical Therapy with Adriamycin in Patients with Superficial Bladder Tumors, in: “Proceedings of the First Conference on Treatment of Urinary Tract Tumors with Adriamycin,” pp 50–57 (1979).
4. H.R. England, J.P. Blandy, and A.M.I. Paris, The Treatment of Single and Multiple Papillary Tumours of the Bladder (Ta/Tl NX MO), in: “Bladder Tumors and Other Topics in Urological Oncology,” M. Pavone-Macaluso, P.H. Smith and F. Edsmyr, eds., Plenum Press, London and New York, pp 343–346 (1980).
5. EORTC Urological Group B, The Treatment of Advanced Carcinoma of the Bladder with a Combination of Adriamycin and 5 Fluorouracil, Eur. Urol. 3: 276 (1977).